Caelum Health
Caelum Health, based in San Francisco, specializes in digital therapeutics for chronic digestive diseases, including a clinically-proven treatment for IBS.
Services
Caelum Health provides personalized and data-driven healthcare solutions aimed at treating chronic digestive diseases. Their services include the development and deployment of digital therapeutics, specifically designed to address digestive health issues such as Irritable Bowel Syndrome (IBS). Utilizing behavioral science, Caelum Health's treatments are clinically proven to offer effective digital interventions for chronic digestive conditions.
Founders
Caelum Health was founded by a dedicated team in San Francisco, CA. Information about individual founders is not provided, but the company is known for its small team size of 2 people. Their combined expertise lies in healthcare and consumer health and wellness, focusing on innovative digital therapeutic solutions.
Products
Caelum Health is building the first clinically-proven digital treatment for digestive health and IBS. Their products are designed to offer personalized healthcare, leveraging data-driven approaches and behavioral science techniques. These digital therapeutics aim to improve patient outcomes through scientifically backed methods, providing a new standard in treating chronic digestive diseases.
History
Caelum Health was established in April 2017. The company is located in San Francisco, CA, and is a part of the Y Combinator S17 batch. Since its inception, Caelum Health has focused on creating innovative solutions in the healthcare industry, particularly in the consumer health and wellness sub-industry. They have gained recognition for developing the first clinically-proven digital treatment for digestive health.
Industry and Regions
Caelum Health operates within the healthcare industry, specifically in the sub-industry of consumer health and wellness. They provide solutions that cater to regions within the United States of America and Canada, focusing on chronic digestive health issues. The company's innovative approach to digital therapeutics aligns with the evolving trends in healthcare, emphasizing personalized and data-driven treatment methods.